Search results
Results from the WOW.Com Content Network
Probably the best-known dementia screening test of this kind is the mini–mental state examination. A disadvantage of such tests is that they are affected by the person's level of education, familiarity with the dominant language and culture in their country, and level of intelligence before the onset of dementia. [1]
A recently conducted study in Australia [8] found that the GPCOG in comparison to the MMSE and Rowland Universal Dementia Assessment Scale (RUDAS) [9] was best to rule out dementia in a multicultural cohort of 151 community-dwelling persons. [8] Its sensitivity was higher (98.1) as compared to MMSE and RUDAS (84.3 and 87.7, respectively).
Dementia is an umbrella term for diseases affecting a person’s abilities to remember, think, and communicate. Currently, the most common type of dementia is Alzheimer’s disease . With all ...
An estimated 5.8 million people in the U.S. have Alzheimer’s disease and related dementias, but the condition can be tricky to diagnose.Patients usually are put through a series of tests, and it ...
The MoCA is a one-page 30-point test administered in approximately 10 minutes. [2] The test and administration instructions are available for clinicians online. The test is available in 46 languages and dialects (as of 2017). In this clock drawing task, the subject is asked to draw a clock with the hours and showing the time 2:30.
For premium support please call: 800-290-4726 more ways to reach us
Diagnosis of mixed dementia can be difficult, as often only one type will predominate. This makes the treatment of people with mixed dementia uncommon, with many people missing out on potentially helpful treatments. Mixed dementia can mean that symptoms onset earlier, and worsen more quickly since more parts of the brain will be affected. [15]
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [ 1 ] and is considered to be the “gold standard” for assessing antidementia treatments.